Clinical Trial Update: Effects of Raloxifene on Hormone Levels [Phase 2]

View source ↗

Summary

Phase 2 trial update examining the effects of raloxifene on hormone levels in breast cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Raloxifene (Evista) (raloxifene)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED